Terrence Wu

Terrence Wu

Auto-generated profile, based on publicly available information

Terrence Wu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2022 in Applied Microbiology
Verified
Journal Article
Open access
PDF file
PJPeter Anto Johnson
Peter Anto Johnson
AWAlyssa Wu
Alyssa Wu
JJJohn Christy Johnson
John Christy Johnson
ZSZachary Schauer
Zachary Schauer
TWTerrence Wu
Terrence Wu
ALAcademic Editor: Firstname Lastname
Academic Editor: Firstname Lastname
The role of viruses has been studied extensively for use as curative cancer therapies. However, the natural immunogenicity of viruses and their interaction with the host’s immune system needs to be examined to determine the full effectiveness of the viral treatment. The prevalence of cancer is increasing globally, and treatments are needed to support the increasing body of patient care. Oncolytic viral therapies used existing pathogenic viruses, which are genetically modified to not cause disease in humans when administered using a vaccine viral vector. Immunotherapies are another avenue of recent interest that has gained much traction. This review will discuss oncolytic viral approaches using three DNA-based viruses, including herpes simplex virus (HSV), vaccinia virus, and adenovirus; as well as four RNA-based viruses, including reovirus, Newcastle disease virus (NDV), poliovirus, and measles virus (MV). It also examines the novel field of cancer-based immunotherapies.